SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-119086
Filing Date
2020-04-24
Accepted
2020-04-24 16:14:03
Documents
3
Period of Report
2020-06-12
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d892627ddef14a.htm DEF 14A 317681
2 GRAPHIC g892627dsp034.jpg GRAPHIC 60983
3 GRAPHIC g892627dsp035.jpg GRAPHIC 66520
  Complete submission text file 0001193125-20-119086.txt   494620
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39041 | Film No.: 20815101
SIC: 2834 Pharmaceutical Preparations